MedTrace Logo

Multicenter Tissue Registry in Melanoma

NCT05750511 · Status: UNKNOWN · Type: OBSERVATIONAL · Enrollment: 1000

Last updated 2023-03-01

No results posted yet for this study

Summary

The prospective multicenter translational study Tissue Registry in Melanoma (ADOREG/TRIM; CA209-578) aimed to validate the Tumor Mutational Burden (TMB) and the PD-L1 expression (PD-L1) from a pre-therapeutically obtained tumor tissue sample as a predictor of a subsequent systemic therapy in a large real-world cohort of metastatic melanoma patients.

Conditions

Interventions

DIAGNOSTIC_TEST

molecular tissue analysis

Sponsors & Collaborators

  • Dermatologic Cooperative Oncology Group

    lead OTHER

Principal Investigators

  • Dirk Schadendorf, MD · Dermatologic Cooperative Oncology Group

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2014-02-01
Primary Completion
2024-02-01
Completion
2025-02-01

Countries

  • Germany

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05750511 on ClinicalTrials.gov